Platinum-based chemotherapy: trends in organic nanodelivery systems

João A. V. Santos, Daniela Silva, Maria Paula M. Marques and Luís A. E. Batista de Carvalho

Nanoscale, 2024, 16, 14640
DOI: 10.1039/D4NR01483A

Dinuclear nitrido-bridged osmium complexes inhibit the mitochondrial calcium uniporter and protect cortical neurons against lethal oxygen–glucose deprivation

Joshua J. Woods, Robyn J. Novorolsky, Nicholas P. Bigham, George S. Robertson and Justin J. Wilson

RSC Chem. Biol., 2023, 4, 84
DOI: 10.1039/D2CB00189F

Platinum(iv) combo prodrugs containing cyclohexane-1R,2R-diamine, valproic acid, and perillic acid as a multiaction chemotherapeutic platform for colon cancer

Elisabetta Gabano, Marzia Bruna Gariboldi, Emanuela Marras, Francesca Barbato and Mauro Ravera

Dalton Trans., 2023, 52, 11349
DOI: 10.1039/D3DT01876H

Screening of molecular targets and construction of a ceRNA network for oxaliplatin resistance in colorectal cancer

Wu Wei, Yang Xi, Xu Jiamin, Zhuang Jing and Han Shuwen

RSC Adv., 2019, 9, 31413
DOI: 10.1039/C9RA06146K

Exploring Ovarian Cancer Cell Resistance to Rhenium Anticancer Complexes

Sierra C. Marker, A. Paden King, Robert V. Swanda, Brett Vaughn, Eszter Boros, Shu‐Bing Qian and Justin J. Wilson

Angewandte Chemie, 2020, 132, 13493
DOI: 10.1002/ange.202004883

An anti-neoplastic tale of metformin through its transport

Firoz Khan Bhati and Manoj Kumar Bhat

Life Sciences, 2024, 357, 123060
DOI: 10.1016/j.lfs.2024.123060

A study on metabolic characteristics and metabolic markers of gastrointestinal tumors

Shan Cong, shanshan Bai, Minghao Zhang, yanfang Bi, yu Wang, shi Jin and hui He

Cancer Biology & Therapy, 2023, 24
DOI: 10.1080/15384047.2023.2255369

Efficacy of Electrochemotherapy with Bleomycin, Oxaliplatin, or Oxaliplatin with Bevacizumab in the Treatment of Colorectal Hepatic Metastases in Rats

Antonios E. Spiliotis, Orestis Mallis Kyriakides, Sebastian Holländer, Gudrun Wagenpfeil, Matthias W. Laschke, Matthias Glanemann and Gereon Gäbelein

Cancers, 2025, 17, 2753
DOI: 10.3390/cancers17172753

Bifunctional Oxaliplatin (IV) Prodrug Based pH-Sensitive PEGylated Liposomes for Synergistic Anticancer Action Against Triple Negative Breast cancer

Lavkesh Bhute, Sayali Dighe, Oly Katari, Vivek Yadav and Sanyog Jain

AAPS PharmSciTech, 2024, 26
DOI: 10.1208/s12249-024-02988-3

MT2A Promotes Oxaliplatin Resistance in Colorectal Cancer Cells

Zhicheng Zhao, Guojing Zhang and Weidong Li

Cell Biochem Biophys, 2020, 78, 475
DOI: 10.1007/s12013-020-00930-5

Platinum-resistant ovarian cancer: From drug resistance mechanisms to liquid biopsy-based biomarkers for disease management

Mohammad Aslam Khan, Kunwar Somesh Vikramdeo, Sarabjeet Kour Sudan, Seema Singh, Annelise Wilhite, Santanu Dasgupta, Rodney Paul Rocconi and Ajay Pratap Singh

Seminars in Cancer Biology, 2021, 77, 99
DOI: 10.1016/j.semcancer.2021.08.005

YTHDF3 Facilitates eIF2AK2 and eIF3A Recruitment on mRNAs to Regulate Translational Processes in Oxaliplatin-Resistant Colorectal Cancer

Yang Zhao, Hongchao Zhao, Danhuan Zhang, Qiuying Quan, Yan Ge, Liantao Li and Lingchuan Guo

ACS Chem. Biol., 2022, 17, 1778
DOI: 10.1021/acschembio.2c00131

Inhibitory effects of flavonoids on organic cation transporter 1: Implications for food/herb-drug interactions and hepatoprotective effects

Wanting Bai, Huixin Tan, Xiaoyan Duan, Jiahuan Hu, Fenghe Wang, Jinjin Wu, Jie Bai and Jinping Hu

Food and Chemical Toxicology, 2024, 193, 114983
DOI: 10.1016/j.fct.2024.114983

Lipid, polymeric, inorganic-based drug delivery applications for platinum-based anticancer drugs

Tugce Boztepe, Guillermo R. Castro and Ignacio E. León

International Journal of Pharmaceutics, 2021, 605, 120788
DOI: 10.1016/j.ijpharm.2021.120788

Investigation of Siderophore–Platinum(IV) Conjugates Reveals Differing Antibacterial Activity and DNA Damage Depending on the Platinum Cargo

Chuchu Guo, Kwo-Kwang A. Wang and Elizabeth M. Nolan

ACS Infect. Dis., 2024, 10, 1250
DOI: 10.1021/acsinfecdis.3c00686

Redox Stability Controls the Cellular Uptake and Activity of Ruthenium‐Based Inhibitors of the Mitochondrial Calcium Uniporter (MCU)

Joshua J. Woods, James Lovett, Barry Lai, Hugh H. Harris and Justin J. Wilson

Angewandte Chemie, 2020, 132, 6544
DOI: 10.1002/ange.202000247

The Temperature-Dependent Effectiveness of Platinum-Based Drugs Mitomycin-C and 5-FU during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer Cell Lines

Roxan F.C.P.A. Helderman, Daan R. Löke, Jan Verhoeff, Hans M. Rodermond, Gregor G.W. van Bochove, Menno Boon, Sanne van Kesteren, Juan J. Garcia Vallejo, H. Petra Kok, Pieter J. Tanis, Nicolaas A.P. Franken, Johannes Crezee and Arlene L. Oei

Cells, 2020, 9, 1775
DOI: 10.3390/cells9081775

Drug-Drug Interactions at Organic Cation Transporter 1

Shiwei Zhou, Sujuan Zeng and Yan Shu

Front. Pharmacol., 2021, 12
DOI: 10.3389/fphar.2021.628705

Copper transporter Ctr1 contributes to enhancement of the sensitivity of cisplatin in esophageal squamous cell carcinoma

Xin Wang, Qianqian Lou, Tianli Fan, Qing Zhang, Xiangxiang Yang, Hongtao Liu and Ruitai Fan

Translational Oncology, 2023, 29, 101626
DOI: 10.1016/j.tranon.2023.101626

Oxaliplatin and its derivatives – An overview

Paul D. O'Dowd, Darragh F. Sutcliffe and Darren M. Griffith

Coordination Chemistry Reviews, 2023, 497, 215439
DOI: 10.1016/j.ccr.2023.215439

Modulating Chemosensitivity of Tumors to Platinum-Based Antitumor Drugs by Transcriptional Regulation of Copper Homeostasis

Yu-Hsuan Lai, Chin Kuo, Macus Tien Kuo and Helen H. W. Chen

IJMS, 2018, 19, 1486
DOI: 10.3390/ijms19051486

Ultrasensitive and selective molecularly imprinted electrochemical oxaliplatin sensor based on a novel nitrogen-doped carbon nanotubes/Ag@cu MOF as a signal enhancer and reporter nanohybrid

Mater H. Mahnashi, Ashraf M. Mahmoud, Khalid Alhazzani, A. Z. Alanazi, Ali Mohammed Alaseem, Mohammad M. Algahtani and Mohamed M. El-Wekil

Microchim Acta, 2021, 188
DOI: 10.1007/s00604-021-04781-6

Model-informed drug repurposing of proton pump inhibitors for the prevention of oxaliplatin induced peripheral neuropathy: A real-world data analysis and pharmacometrics approach

Yasuhito Tsukushi, Kanade Koriyama, Shinji Kobuchi, Kenjiro Matsumoto, Yukako Ito and Toshiyuki Sakaeda

Cancer Chemother Pharmacol, 2025, 95
DOI: 10.1007/s00280-025-04801-9

Elesclomol induces copper‐dependent ferroptosis in colorectal cancer cells via degradation of ATP7A

Wei Gao, Zhao Huang, Jiufei Duan, Edouard C. Nice, Jie Lin and Canhua Huang

Molecular Oncology, 2021, 15, 3527
DOI: 10.1002/1878-0261.13079

Dual acting oxaliplatin (IV) prodrug loaded albumin nanoparticles for safer synergistic anticancer action against triple negative breast cancer

Kshitija Abhang, Sayali Dighe, Oly Katari, Vivek Yadav and Sanyog Jain

Drug Deliv. and Transl. Res., 2025
DOI: 10.1007/s13346-025-01833-9

In silico identification of the specific pathways in each stage of colorectal cancer and the association of their top genes with drug resistance and sensitivity

Reza Hashemi, Maryam Peymani, Kamran Ghaedi and Hana Saffar

Med Oncol, 2022, 39
DOI: 10.1007/s12032-022-01661-8

Metal- and metalloid-based compounds to target and reverse cancer multidrug resistance

Andreia Valente, Ana Podolski-Renić, Isabella Poetsch, Nenad Filipović, Óscar López, Iztok Turel and Petra Heffeter

Drug Resistance Updates, 2021, 58, 100778
DOI: 10.1016/j.drup.2021.100778

Redox Stability Controls the Cellular Uptake and Activity of Ruthenium‐Based Inhibitors of the Mitochondrial Calcium Uniporter (MCU)

Joshua J. Woods, James Lovett, Barry Lai, Hugh H. Harris and Justin J. Wilson

Angew Chem Int Ed, 2020, 59, 6482
DOI: 10.1002/anie.202000247

Deciphering the Molecular Mechanisms behind Drug Resistance in Ovarian Cancer to Unlock Efficient Treatment Options

Mariana Nunes, Carla Bartosch, Miguel Henriques Abreu, Alan Richardson, Raquel Almeida and Sara Ricardo

Cells, 2024, 13, 786
DOI: 10.3390/cells13090786

Transcriptomic profiling of hepatic tissues for drug metabolism genes in nonalcoholic fatty liver disease: A study of human and animals

Li Chen, Lu Chen, Xu Li, Lin Qin, Yan Zhu, Qianru Zhang, Daopeng Tan, Yuqi He and Yu-He Wang

Front. Endocrinol., 2023, 13
DOI: 10.3389/fendo.2022.1034494

Application of Approved Cisplatin Derivatives in Combination Therapy against Different Cancer Diseases

Dobrina Tsvetkova and Stefka Ivanova

Molecules, 2022, 27, 2466
DOI: 10.3390/molecules27082466

Exploring Ovarian Cancer Cell Resistance to Rhenium Anticancer Complexes

Sierra C. Marker, A. Paden King, Robert V. Swanda, Brett Vaughn, Eszter Boros, Shu‐Bing Qian and Justin J. Wilson

Angew Chem Int Ed, 2020, 59, 13391
DOI: 10.1002/anie.202004883

Preventive Efficacy and Safety of Yiqi-Wenjing-Fang Granules on Oxaliplatin-Induced Peripheral Neuropathy: A Protocol for a Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial

Zhancheng Gu, Guoli Wei, Liangjun Zhu, Lingjun Zhu, Jing Hu, Qi Li, Guoxiang Cai, Hong Lu, Min Liu, Chen Chen, Yi Ji, Guochun Li, Jiege Huo and Ching-Chi Chi

Evidence-Based Complementary and Alternative Medicine, 2021, 2021, 1
DOI: 10.1155/2021/5551568

Understanding and targeting resistance mechanisms in cancer

Zi‐Ning Lei, Qin Tian, Qiu‐Xu Teng, John N. D. Wurpel, Leli Zeng, Yihang Pan and Zhe‐Sheng Chen

MedComm, 2023, 4
DOI: 10.1002/mco2.265

Role and recent progress of P2Y12 receptor in cancer development

Yanni Xi, Zhenya Min, Mianxue Liu, Xueqin Lin and Zhao-hua Yuan

Purinergic Signalling, 2024
DOI: 10.1007/s11302-024-10027-w

Cancer Pro-oxidant Therapy Through Copper Redox Cycling: Repurposing Disulfiram and Tetrathiomolybdate

Manuel Rieber

CPD, 2020, 26, 4461
DOI: 10.2174/1381612826666200628022113

Coexisting Molecular Determinants of Acquired Oxaliplatin Resistance in Human Colorectal and Ovarian Cancer Cell Lines

Paul Noordhuis, Adrianus C. Laan, Kasper van de Born, Richard J. Honeywell and Godefridus J. Peters

IJMS, 2019, 20, 3619
DOI: 10.3390/ijms20153619

The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents

Jiabei Zhou, Yu Kang, Lu Chen, Hua Wang, Junqing Liu, Su Zeng and Lushan Yu

Front. Pharmacol., 2020, 11
DOI: 10.3389/fphar.2020.00343

Synergistic Apoptosis-Ferroptosis: Oxaliplatin loaded amorphous iron oxide nanoparticles for High-efficiency therapy of orthotopic pancreatic cancer and CA19-9 levels decrease

Yilong Li, Xinlong Wang, Binbin Ding, Cong He, Can Zhang, Jiating Li, Haonian Wang, Zhibo Li, Gang Wang, Yongwei Wang, Hua Chen, Ping'an Ma and Bei Sun

Chemical Engineering Journal, 2023, 464, 142690
DOI: 10.1016/j.cej.2023.142690

Copper(I) Complexes With Phenanthroline‐Functionalized NHC Ligands Achieve Effective Anticancer Activity via Mitochondrial and Endoplasmic Reticulum Stress

Chao Chen, Yilun Zheng, Hong Rao, Fan Huang, Chao Shen and Chunxin Lu

Applied Organom Chemis, 2025, 39
DOI: 10.1002/aoc.7756